This novel medication, developed by Eli Lilly, has shown promising results in clinical trials, offering significant benefits for people living with obesity and prediabetes
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo
C., Wunschmann, J., Lendzian, K
Absolute and Relative Contraindications Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use GLP-1 receptor agonists due to thyroid C-cell tumor risk observed in animal studies
If you're getting these questions from patients and don't have a reliable pharmacy relationship yet, or you're not fully happy with the one you have, let's talk
Clinical Update 6/18/2019 Fish Oil for Heart Failure